The transition of metabolic phenotypes and cardiovascular events: Panasonic cohort study 16
- PMID: 38444281
- DOI: 10.1002/oby.23999
The transition of metabolic phenotypes and cardiovascular events: Panasonic cohort study 16
Abstract
Objective: The study objective was to investigate whether changes in metabolic phenotype affect the risk of cardiovascular events.
Methods: All 117,589 participants were included in this retrospective cohort study. The metabolic phenotypes of the participants were assessed at two points (the second evaluation was set 2 years after the first evaluation), and the incidence rate of cardiovascular events was observed for 11 years. The main outcome was 3-point major adverse cardiac events (MACE), which comprises cardiovascular death, nonfatal coronary artery disease, and nonfatal stroke incidence.
Results: Of the participants, 2748 (2.3%) cases of 3-point MACE were identified during follow-up. The stable metabolically healthy obesity group had a higher risk of 3-point MACE than those with stable metabolically healthy nonobesity (MHNO). Additionally, the change from metabolically healthy obesity to MHNO for 2 years decreased the risk of 3-point MACE (hazard ratio [HR], 1.12: 95% CI: 0.84-1.47) to the same level as stable MHNO. However, the change from metabolically abnormal nonobesity and metabolically abnormal obesity to MHNO for 2 years maintained a higher risk of 3-point MACE (HR, 1.66 [95% CI: 1.36-2.01]; HR, 1.91 [95% CI: 1.22-2.81]) than those with stable MHNO.
Conclusions: Change in metabolic phenotype is associated with incident 3-point MACE.
© 2024 The Obesity Society.
References
REFERENCES
-
- Swinburn BA, Sacks G, Hall KD, et al. The global obesity pandemic: shaped by global drivers and local environments. Lancet. 2011;378(9793):804‐814. doi:10.1016/S0140‐6736(11)60813‐1
-
- World Health Organization. Obesity and overweight. Published June 9, 2021. Accessed January 26, 2023 https://www.who.int/news-room/fact-sheets/detail/obesity-and-overweight
-
- Saltiel AR, Olefsky JM. Inflammatory mechanisms linking obesity and metabolic disease. J Clin Invest. 2017;127(1):1‐4. doi:10.1172/JCI92035
-
- Kotsis V, Stabouli S, Papakatsika S, Rizos Z, Parati G. Mechanisms of obesity‐induced hypertension. Hypertens Res. 2010;33(5):386‐393. doi:10.1038/hr.2010.9
-
- van Gaal LF, Mertens IL, de Block CE. Mechanisms linking obesity with cardiovascular disease. Nature. 2006;444(7121):875‐880.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources